Primary seborrhoea in English springer spaniels: a retrospective study of 14 cases

Genes of Congenital Dermatologic Disorders in Dogs—A Review

This article presents an overview of up-to-date identified genes responsible for congenital canine skin diseases of dogs and the characteristics of these diseases. Congenital skin diseases constitute a specific group of dermatologic disorders that plays an important role in breeding of purebred dogs. They include primary seborrhoea, ichthyosis, hereditary nasal parakeratosis, dermatomyositis, colour dilution alopecia, skin mucinosis, dermoid sinus, lethal acrodermatitis, acral mutilation syndrome, keratoconjunctivitis sicca, ichthyosiform dermatosis, bullous epidermolysis, exfoliative dermal lupus erythematosus, congenital footpad hyperkeratosis and sebaceous adenitis. In the majority of cases, their occurrence is linked to particular breeds. In more than half of these diseases a specific defective gene variant responsible for the disease has been identified. Genetic tests for identification of the relevant defective genes serve as an important tool in the diagnostics of diseases in veterinary practice and in breeding of purebred dogs.

Looking back on 45 years of canine dermatology

In June 2018, I was honored (and flabbergasted!) to receive the Kennel Club Charitable Trust's Lifetime Achievement Award for research in the field of canine health, sponsored by Vernon and Shirley Hill of Metro Bank, and administered by the Kennel Club Charitable Trust. I entered the arena of veterinary dermatology in 1971, a graduate of the University of California, Davis. I retired from Cornell University as the James Law Professor Dermatology Emeritus in 2016. During my 45-year career in veterinary dermatology, I worked with all species, especially dogs, cats, and horses, eventually authoring or co-authoring 694 publications including 12 textbooks. For this personal view I will limit my comments to canine dermatology. I was asked to make this article 'a more reflective piece on my lifetime's work'. This is not at all comfortable for me, as my upbringing encouraged me not to 'toot my own horn'. However, 'toot' I must. Hence, indulge me as I share these very personal views on where we were, where we went, and some of my own dabblings along the way. If I fail to mention one of your favorite remembrances, I apologize. Don't let it get under your skin!

Canine ichthyosis and related disorders of cornification

The stratum corneum acts as a permability barrier to keep the body hydrated while preventing environmental damage and exposure to pathogens and noxious substances. Disorders of cornification (DOC) arise from an inability to form a normal stratum corneum. Most DOC arise secondary to skin allergies, ectoparasitism, endocrine and metabolic diseases. Primary DOC typically arise from single gene mutations. As there is no cure for primary DOC (ichthyoses), a stepwise diagnostic approach is fundamental to establishing a correct diagnosis. Treatment involves a regimen of topical therapy as well as medical scrutiny to address secondary bacterial and yeast infections.

The mast cell in wound healing

This review describes the role of the mast cell in the pathobiology of skin healing. After illustrating its main morphofunctional characteristics, with special reference to the dog and cat, we consider the involvement of the mast cell in the various phases of skin repair. With the aid of a wide array of newly formed or preformed mediators released by degranulation, the activated mast cell controls the key events of the healing phases: triggering and modulation of the inflammatory stage, proliferation of connective cellular elements and final remodelling of the newly formed connective tissue matrix. The importance of the mast cell in regulating healing processes is also demonstrated by the fact that a surplus or deficit of degranulated biological mediators causes impaired repair, with the formation of exuberant granulation tissue (e.g. keloids and hypertrophic scars), delayed closure (dehiscence) and chronicity of the inflammatory stage.